Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control Trial
Key facts
- Who runs it
- Hacettepe University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 39 people enrolled
- Started
- 20 Jun 2022
- Ended
- 16 Jun 2024
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Home-Based Aerobic Exercise Program
- Home-Based Aerobic and Resistance Exercise (ARE) Group
- Record updated
- 8 September 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Being followed up for chronic liver disease or listed on the liver transplant waiting list at the Hacettepe University Department of Internal Medicine, Division of Gastroenterology
- Owning and being able to use a smartphone
- Aged between 18 and 70 years
- Receiving primary prophylactic treatment for gastroesophageal varices
- Willingness to participate in the study
Who cannot take part
- Previous liver transplantation
- Pulmonary vascular complications of portal hypertension
- Chronic renal failure requiring dialysis
- Human Immunodeficiency Virus (HIV) infection
- Recent acute myocardial infarction
- Uncontrolled arrhythmias causing symptomatic hemodynamic instability
- Physical or orthopedic conditions preventing home-based exercise training
- Hemoglobin level below 10 g/dL
- Creatinine level above 2 mg/dL
- Inability to own or use a smartphone
- Participation in an exercise training program within the last year
- High-risk varices without beta-blocker treatment
- Presence of persistent hepatic encephalopathy
- Hepatic hydrothorax
- Presence of hepatocellular carcinoma (HCC)
- Contraindications to maximal exercise testing
- Lack of willingness to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether home-based exercise interventions, including aerobic exercise (AE) and a combination of aerobic and resistance exercise (ARE), can improve physical and health-related outcomes in patients with chronic liver disease (CLD). The primary population includes adult patients with CLD experiencing complications such as sarcopenia, malnutrition, and fatigue.
Read full original descriptionShow less
The main questions it aims to answer are:
Does home-based ARE improve oxygen consumption, muscle strength, and physical frailty more effectively than AE or no exercise? Can home-based exercise reduce fatigue and improve quality of life and health-related behaviors?
Researchers will compare the outcomes of three groups:
Home-based AE group Home-based ARE group Control group (physical activity counselling)
Participants will:
Perform an 8-week home-based exercise program based on their group allocation (either AE or ARE).
Undergo evaluations before and after the intervention, including:
Oxygen consumption (via cardiopulmonary exercise testing) Muscle strength (using a hand dynamometer and respiratory muscle strength tests) Body composition (via bioelectrical impedance analysis and skinfold thickness measurements) Quadriceps muscle thickness and cross-sectional area (using muscle ultrasound) Muscle oxygenation Fatigue levels (using the Fatigue Severity Scale) Physical frailty (using the Liver Frailty Index) Quality of life (using the Chronic Liver Disease Questionnaire) Health-related lifestyle behaviors (using the Health-Promoting Lifestyle Profile II)
The 3 groups in the trial
- Aerobic Exercise (AE) GroupTreatment being tested
Participants in this group performed moderate-intensity aerobic exercises, primarily walking, three non-consecutive days per week for eight weeks. Exercise intensity was set at 40-60% of peak VO2 or based on perceived exertion (Borg 4-6) for those on beta-blockers. Sessions were monitored via video conferencing, and participants used smart wristbands for heart rate tracking.
Treatment: Home-Based Aerobic Exercise Program
- Aerobic and Resistance Exercise (ARE) GroupTreatment being tested
Participants in this group performed a combination of aerobic and resistance exercises. Aerobic sessions followed the same protocol as the AE group (3 days/week). Resistance exercises were performed 2 additional days per week using elastic resistance bands calibrated to 40-50% of 1RM. Each resistance session included 3 sets of 10 repetitions for major muscle groups. All sessions were conducted and monitored remotely.
Treatment: Home-Based Aerobic and Resistance Exercise (ARE) Group
- Control GroupNo study treatment, for comparison
This group does not receive a structured exercise intervention. While they are monitored for daily step counts and encouraged to stay active, there is no specific intervention implemented.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Home-Based Aerobic and Resistance Exercise on Oxygen Consumption, Muscle Function, Frailty, Quality of Life, and Health-Related Lifestyle in Chronic Liver Disease
- Record updated
- 8 September 2026